News | Radiation Therapy | November 03, 2015

Study Finds Gold Nanoparticles Boost Radiation Therapy Effectiveness

Researchers discover element boosts photoelectric effect of radiotherapy, cutting off blood supply to tumors

gold nanoparticles, GNP, radiation therapy boost, AAPM, Medical Physics

November 3, 2015 — Gold nanoparticles (GNPs) can increase the effectiveness of radiation therapy by killing blood vessels that feed cancerous tumors, suggests a new study. The study was published in the current issue of Medical Physics, the monthly journal of the American Association of Physicists in Medicine (AAPM).

Researchers used simulations to assess how GNPs injected into tumors act as vascular disrupting agents, which combat cancer by cutting off blood supply to the tumor. They determined that GNPs get wedged in quickly-growing and therefore vulnerable blood vessels and, when irradiated, rapidly cause the death of those vessels, choking the tumor. They assessed GNPs’ effect on three types of radiation therapy: kV photons, MV photons and proton therapy.

“Our research suggests GNPs can boost the effectiveness of radiation therapy by killing off some of the tumor-feeding blood vessels quickly, before the tumor has the chance to grow new blood vessels,” said Yuting Lin, Ph.D., a medical physics resident with the Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston. “We found that while GNPs cause the largest boost to kV photons, they also can significantly improve radiosensitization for MV photon and proton therapy, especially if the GNPs can be targeted to attach to the vessel walls.”

Gold has a high atomic number, meaning GNPs are more likely to boost the photoelectric effect of radiation therapy, in which electrons are released from the atom and deposit their energy into the surrounding tissue. The simulation shows that when GNPs wedged in blood vessels are irradiated, they produce large amounts of low energy electrons that quickly kill off the nearby tissue. This rapid cell death, known as apoptosis, cuts off part of the blood supply to the tumor. Like all tissue, tumors need a blood supply to grow and thrive.

In the study, researchers looked at 20 Au-mg/g GNP blood concentrations distributed in the blood vessel wall. They determined that these GNP particles increased the radiation dose in the blood vessel wall by 43 percent of the prescribed dose for 250 kVp photons, 1 percent for 6 MV photons and .1 percent for protons. When GNPs are wedged in the inner vascular wall, the dose can rise up to 207 percent of the prescribed dose for 250 kVp photons, 4 percent for 6 MV photons and 2 percent for protons. While the overall increase in dose was small, the high doses around the GNPs could potentially disrupt the vasculature.

Researchers note that if GNPs are designed to actively accumulate in the tumor blood vessel walls, the damage could be increased significantly.

The use of GNP as a radiosensitizer in humans is in early trials and likely will not be widely available for patients for five years or so.

Co-authors of the study in addition to Lin are: Harald Paganetti, Ph.D., Massachusetts General Hospital and Harvard Medical School; Stephen J. McMahon, Ph.D., Queen’s University Belfast, Massachusetts General Hospital and Harvard Medical School; and Jan Schuemann, Ph.D., Massachusetts General Hospital and Harvard Medical School.

For more information:

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
Mobile App Data Collection Shows Promise for Population Health Surveys
News | Population Health | January 10, 2019
Mobile app data collection can bring access to more potential clinical study participants, reduce clinical study...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Magnetic Resonance Imaging (MRI) | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Artificial Intelligence Pinpoints Nine Different Abnormalities in Head Scans

A brain scan (left) showing an intraparenchymal hemorrhage in left frontal region and a scan (right) of a subarachnoid hemorrhage in the left parietal region. Both conditions were accurately detected by the tool. Image courtesy of Nature Medicine.

News | Artificial Intelligence | January 07, 2019
The rise in the use of computed tomography (CT) scans in U.S. emergency rooms has been a well-documented trend1 in...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...